SCHEMBL18359152

SCHEMBL18359152

C[C@H]1CNc2cc(N)ccc2O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.39
CREBBP Q92793 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 1/20 0.35
APAF1 O14727 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B10 Q99714 1/20 0.34
CHRNB4 P30926 4/20 0.32
CHRNA3 P32297 4/20 0.32
CHRNB2 P17787 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1669821 1.00 BRD4 (0.39) BRD4CREBBPSMN1; SMN2KMT2AKDM4E
Hydrochloric Acid SCHEMBL6549729 0.98 BRD4 (0.38) BRD4CREBBPSMN1; SMN2KMT2AKDM4E
SCHEMBL22791978 0.81 CREBBP (0.58) BRD4CREBBPSMN1; SMN2KMT2AGAA
SCHEMBL22791631 0.81 CREBBP (0.58) BRD4CREBBPSMN1; SMN2KMT2AGAA
SCHEMBL21882013 0.79 AKR1B1 (0.39) BRD4CREBBPSMN1; SMN2KMT2AMAPT
SCHEMBL21882006 0.79 AKR1B1 (0.39) BRD4CREBBPSMN1; SMN2KMT2AMAPT
SCHEMBL15074412 0.79 BRD4 (0.48) BRD4CREBBPSMN1; SMN2KMT2ATDP1
SCHEMBL15052871 0.79 BRD4 (0.48) BRD4CREBBPSMN1; SMN2KMT2ATDP1
SCHEMBL21882007 0.79 AKR1B1 (0.39) BRD4CREBBPSMN1; SMN2KMT2AMAPT
SCHEMBL16123162 0.79 PBRM1 (0.47) BRD4CREBBPSMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638014-B1 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF ROR-GAMMA ACTIVITY AND THE TREATMENT OF DISEASES LYCERA CORP (US) 2017-01-04 EP disclosed